Boehringer's Gilotrif widens its reach in crowded EGFR lung cancer field
admin 17th January 2018 Uncategorised 0Boehringer Ingelheim’s Gilotrif is up against some stiff competition in the EGFR lung cancer space. But this week, it snagged a label update that will widen its reach.
More: Boehringer's Gilotrif widens its reach in crowded EGFR lung cancer field
Source: fierce